Monoclonal anti-CD20 antibodies in lymphomas therapy during the COVID-19 pandemic: pro and contra

Monoclonal anti-CD20 antibodies in lymphomas therapy during the COVID-19 pandemic: pro and contraThe review presents the results of a combined analysis of literature data and own clinical observations regarding the safety and feasibility of using monoclonal anti-CD20 antibodies in the treatment of B...

Full description

Saved in:
Bibliographic Details
Main Authors: K. A. Sychevskaya, S. K. Kravchenko
Format: Article
Language:Russian
Published: ABV-press 2022-04-01
Series:Онкогематология
Subjects:
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/542
Tags: Add Tag
No Tags, Be the first to tag this record!